Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.

Cirugia Cardiovascular is a distinguished open-access journal published by Elsevier, dedicated to advancing the field of cardiovascular surgery and medicine. Established in Spain, this journal serves as a vital platform for disseminating innovative research and clinical insights in the realms of cardiology and surgical practices. With its ISSN 1134-0096 and E-ISSN 1134-0096, Cirugia Cardiovascular has been making impactful contributions to the medical community since becoming an open-access publication in 2005, thus ensuring unrestricted access to critical knowledge. In the most recent evaluation, it was positioned in the Q4 category in both Cardiology and Cardiovascular Medicine and Surgery as of 2023, reflecting its ongoing commitment to improving its scholarly impact. Despite its current ranking within the Scopus database, which highlights its value at percentile ranks of 19th in Surgery and 12th in Cardiology and Cardiovascular Medicine, Cirugia Cardiovascular continues to embrace growth and innovation. The journal aims to unite researchers, clinicians, and students, fostering a collaborative environment to elevate cardiovascular healthcare practices. With a converged year range from 2012 to 2024, it optimally addresses contemporary challenges and advancements in cardiovascular surgical techniques and outcomes.

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.

Gastroenterology Report, published by Oxford University Press, is a leading Open Access journal dedicated to advancing the field of gastroenterology. Since its inception in 2013, this journal has become a vital resource for researchers, clinicians, and students, providing them with access to high-quality, peer-reviewed articles that span a wide range of topics in gastrointestinal health and disease. With an impressive Q2 ranking in gastroenterology and holding a position of #66 out of 167 in Scopus rankings, it reflects the growing impact and relevance of its published research. The objective of the Gastroenterology Report is to foster interdisciplinary collaboration and disseminate crucial findings that can improve patient outcomes and shape future studies. As the journal converges its efforts from 2014 to 2024, it continues to strengthen its role as a premier outlet for innovative research and clinical advances in the dynamic field of gastroenterology.

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.